Endurant Capital Management LP Biodesix Inc Transaction History

Endurant Capital Management LP

  • $0
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.52 - $2.5 $16,967 - $27,907
-11,163 Reduced 8.97%
113,267 $210,000
Q4 2022

Feb 14, 2023
SELL
$0.98 - $2.3 $5,591 - $13,123
-5,706 Reduced 4.38%
124,430 $286,000
Q3 2022

Nov 14, 2022
SELL
$1.24 - $2.89 $765 - $1,783
-617 Reduced 0.47%
130,136 $165,000
Q1 2022

May 16, 2022
BUY
$1.69 - $5.81 $220,972 - $759,674
130,753 New
130,753 $221,000

Others Institutions Holding BDSX

# of Institutions
58
Shares Held
62.3M
Call Options Held
2.6K
Put Options Held
10.1K
View Full List

About BIODESIX INC

BDSX Quotes by TradingView
  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $55.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email